Persistence of symptoms in dengue patients: a clinical cohort study

被引:12
|
作者
Tiga-Loza, Diana Carolina [1 ,2 ]
Martinez-Vega, Ruth A. [3 ]
Undurraga, Eduardo A. [4 ,5 ]
Tschampl, Cynthia A. [6 ]
Shepard, Donald S. [6 ]
Ramos-Castaneda, Jose [2 ,7 ]
机构
[1] Univ Manuela Beltran, Programa Enfermeria, Santander, Spain
[2] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico
[3] Univ Ind Santander, Escuela Microbiol, Santander, Spain
[4] Pontificia Univ Catolica Chile, Escuela Gobierno, Santiago, Chile
[5] Millennium Nucleus Study Life Course & Vulnerabil, Santiago, Chile
[6] Brandeis Univ, Schneider Inst Hlth Policy, Heller Sch, Waltham, MA USA
[7] Univ Anahuac, Ctr Invest Ciencias Salud, Naucalpan De Juarez, Mexico
关键词
cohort study; convalescence; dengue; persistent symptoms; signs and symptoms; SYSTEMATIC ANALYSIS; ECONOMIC BURDEN; VIRUS-INFECTION; GLOBAL BURDEN; 195; COUNTRIES; DISEASE; FEVER; TERRITORIES; ASSOCIATION;
D O I
10.1093/trstmh/traa007
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Dengue is commonly considered an acute illness and follows three phases: febrile, critical in some cases and recovery. However, a number of studies have described a continuation of dengue symptoms for weeks or months, extending the recovery phase. Here we evaluate this persistence of dengue symptoms during convalescence. Methods: Our clinical cohort study included patients who sought medical services 48 to 144 h from the onset of fever at seven hospitals or ambulatory centers in Morelos, Mexico. Seventy-nine laboratory-confirmed dengue patients were followed up regularly using clinic and/or home visits and telephone calls for as long as symptoms persisted or up to 6 mo. Results: In total, 55.7% of patients had dengue-related symptoms 1 mo after the onset of fever; pain and dermatological manifestations were the most common persistent symptoms. Prognostic factors for symptom persistence were: >= 4 d of fever (RR 1.72; 95% CI 1.35 to 2.19), platelet count <= 100000/mm(3) (RR 1.20; 95% CI 1.20 to 2.20), petechiae/bruises (RR 1.97; 95% CI 1.56 to 2.48) and abdominal pain/hepatomegaly (RR 1.79; 95% CI 1.41 to 2.28). Conclusions: Persistence of dengue symptoms were common in laboratory-confirmed dengue patients. Manifestations related to tissue damage were associated with persistence after 30 d; host characteristics, such as age and health status before infection, were associated with prolonged persistence (>60 d). The burden of dengue may be higher than previously estimated.
引用
收藏
页码:355 / 364
页数:10
相关论文
共 50 条
  • [41] Potential biomarkers for the clinical prognosis of severe dengue
    Carneiro da Silva, Mayara Marques
    Vega Gonzales Gil, Laura Helena
    de Azevedo Marques Junior, Ernesto Torres
    Calzavara-Silva, Carlos Eduardo
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2013, 108 (06): : 755 - 762
  • [42] Clinical and laboratory factors associated with mortality in dengue
    Saroch, Atul
    Arya, Vivek
    Sinha, Nitin
    Taneja, R. S.
    Sahai, Pooja
    Mahajan, R. K.
    TROPICAL DOCTOR, 2017, 47 (02) : 141 - 145
  • [43] Prognostic factors in severe dengue patients: A multi-center retrospective cohort study
    Yang, Cheng-Hsun
    Lee, Ing-Kit
    Chen, Yi-Chun
    Huang, Wen-Chi
    Hsu, Jui-Chi
    Tai, Chien-Hsiang
    Huang, Chung-Hao
    Lin, Chun-Yu
    Chen, Yen-Hsu
    PLOS NEGLECTED TROPICAL DISEASES, 2025, 19 (01):
  • [44] Clinical course of dengue in patients with thalassaemia
    Natesirinilkul, Rungrote
    Tantiworawit, Adisak
    Charoenkwan, Pimlak
    PAEDIATRICS AND INTERNATIONAL CHILD HEALTH, 2013, 33 (01) : 32 - 36
  • [45] Relationship between clinical and laboratory features with infecting dengue virus serotypes in a sample of dengue suspected adult patients from 2015-2017 in Sri Lanka
    Wijesinghe, Chandana
    Jabeer, Afzal A.
    Iqbal, Bushran N.
    Noordeen, Faseeha
    JOURNAL OF CLINICAL VIROLOGY PLUS, 2022, 2 (04):
  • [46] A community-based prospective cohort study of dengue viral infection in Malaysia: the study protocol
    Jahan, Nowrozy Kamar
    Ahmad, Mohtar Pungut
    Dhanoa, Amreeta
    Meng, Cheong Yuet
    Ming, Lau Wee
    Reidpath, Daniel D.
    Allotey, Pascale
    Zaini, Anuar
    Phipps, Maude Elvira
    Fatt, Quek Kia
    Rabu, Aman Bin
    Sirajudeen, Rowther
    Fatan, Ahmad AbdulBasitz Ahmad
    Ghafar, Faidzal Adlee
    Ahmad, Hamdan Bin
    Othman, Iekhsan
    SyedHassan, Sharifah
    INFECTIOUS DISEASES OF POVERTY, 2016, 5
  • [47] A prospective cohort study to evaluate peridomestic infection as a determinant of dengue transmission: Protocol
    Arali Martinez-Vega, Ruth
    Danis-Lozano, Rogelio
    Velasco-Hernandez, Jorge
    Alexander Diaz-Quijano, Fredi
    Gonzalez-Fernandez, Mariana
    Santos, Rene
    Roman, Susana
    Argaez-Sosa, Jorge
    Nakamura, Miguel
    Ramos-Castaneda, Jose
    BMC PUBLIC HEALTH, 2012, 12
  • [48] Development of Inapparent Dengue Associated With Increased Antibody Levels to Aedes aegypti Salivary Proteins: A Longitudinal Dengue Cohort in Cambodia
    Manning, Jessica E.
    Chea, Sophana
    Parker, Daniel M.
    Bohl, Jennifer A.
    Lay, Sreyngim
    Mateja, Allyson
    Man, Somnang
    Nhek, Sreynik
    Ponce, Aiyana
    Sreng, Sokunthea
    Kong, Dara
    Kimsan, Soun
    Meneses, Claudio
    Fay, Michael P.
    Suon, Seila
    Huy, Rekol
    Lon, Chanthap
    Leang, Rithea
    Oliveira, Fabiano
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (08) : 1327 - 1337
  • [49] A Comprehensive Study of Dengue Epidemics and Persistence of Anti-Dengue Virus Antibodies in District Swat, Pakistan
    Ahmad, Naveed
    Khan, Tariq
    Jamal, Syed Muhammad
    INTERVIROLOGY, 2020, 63 (1-6) : 46 - 56
  • [50] Clinical, laboratory, and demographic determinants of hospitalization due to dengue in 7613 patients: A retrospective study based on hierarchical models
    da Silva, Natal Santos
    Undurraga, Eduardo A.
    da Silva Ferreira, Elis Regina
    Estofolete, Cassia Fernanda
    Nogueira, Mauricio Lacerda
    ACTA TROPICA, 2018, 177 : 25 - 31